RT Journal Article
SR Electronic
T1 Combined Use of Stress Echocardiography and Cardiopulmonary Exercise Testing to Assess Exercise Intolerance after Acute Myocardial Infarction
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.23.20169821
DO 10.1101/2020.08.23.20169821
A1 Smarz, Krzysztof
A1 Jaxa-Chamiec, Tomasz
A1 Zaborska, Beata
A1 Tysarowski, Maciej
A1 Budaj, Andrzej
YR 2020
UL http://medrxiv.org/content/early/2020/08/24/2020.08.23.20169821.abstract
AB Background Exercise capacity (EC) after acute myocardial infarction (AMI) influences prognosis, but the causes of its reduction are complex and not sufficiently studied.Methods We prospectively enrolled consecutive patients who underwent percutaneous coronary intervention for their first AMI with left ventricular ejection fraction (LV EF) >40% at least 4 weeks after AMI. We performed combined stress echocardiography and cardiopulmonary exercise testing (CPET-SE) using a semi-supine cycle ergometer to determine predictors of EC (peak oxygen uptake [VO2]).Results Among 81 patients (70% male, mean age 58 ± 11 years), 40% had AMI with ST-segment elevation, and 60% non ST-segment elevation, LV EF was 57 ± 7%; wall motion score index, 1.18 (IQR 1.06 – 1.31); peak VO2, 19.5 ± 5.4 mL/kg/min. Multivariate analysis revealed that parameters at peak exercise: heart rate (β = 0.17, p < 0.001), stroke volume (β = 0.09, p < 0.001), and arteriovenous oxygen difference (A-VO2Diff, β = 93.51, p < 0.001) were independently positively correlated with peak VO2, with A-VO2Diff being its strongest contributor.Conclusions In patients treated for AMI with normal/mildly reduced LV EF, EC is associated with peak peripheral oxygen extraction as well as peak heart rate and peak stroke volume. CPET-SE is a useful tool to evaluate decreased fitness in this group.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the Centre of Postgraduate Medical Education, Warsaw, Poland [grant number: 501-1-10-14-15]. The sponsor did not contribute in study design; in the collection, analysis and interpretation of data.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted in conformance with the requirements set out in the Declaration of Helsinki. All patients provided written consent to participate. The study and all its protocols were approved by the Bioethical Committee of the Centre of Postgraduate Medical Education.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe complete raw dataset can be accessed via the Mendeley Data below. https://data.mendeley.com/datasets/dphcf83ty6/2